Creating A Drug Delivery ARMMs Race episode artwork

EPISODE · Aug 7, 2024 · 24 MIN

Creating A Drug Delivery ARMMs Race

from The Bio Report · host Levine Media Group

While there have been a parade of novel therapeutic modalities in recent years, many of them are constrained by delivery challenges. Vesigen Therapeutics is developing novel drug delivery technology known as ARMMs that can transport a wide range of therapeutic payloads directly into the cytoplasm of target cells. We spoke to Paulash Mohsen, CEO of Vesigen, about the company’s delivery technology, its advantages over viral vectors and liquid nanoparticles, and how it enables the targeting of previously undruggable targets.

Paulash Mohsen, CEO of Vesigen Therapeutics, discusses the company’s delivery technology, its advantages over viral vectors and liquid nanoparticles, and how they enable the targeting of previously undruggable targets.

NOW PLAYING

Creating A Drug Delivery ARMMs Race

0:00 24:42

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Bio Report?

This episode is 24 minutes long.

When was this The Bio Report episode published?

This episode was published on August 7, 2024.

What is this episode about?

While there have been a parade of novel therapeutic modalities in recent years, many of them are constrained by delivery challenges. Vesigen Therapeutics is developing novel drug delivery technology known as ARMMs that can transport a wide range of...

Can I download this The Bio Report episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!